Genomic progress in pediatric arthritis: Recent work and future goals

Current Opinion in Rheumatology

Volumn 18, Issue 5, 2006, Pages 482-489

  Phelan, James D ^a   Thompson, Susan D ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Autoimmune; Candidate gene; Genetic association; Juvenile idiopathic arthritis; Juvenile rheumatoid arthritis; Susceptibility traits

Indexed keywords

BIOLOGICAL MARKER;

AUTOIMMUNITY; CHILD; CHRONIC DISEASE; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GENETIC LINKAGE; GENETIC TRAIT; GENOME ANALYSIS; HUMAN; IDIOPATHIC DISEASE; JUVENILE RHEUMATOID ARTHRITIS; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ADOLESCENT; AGE FACTORS; ARTHRITIS, JUVENILE RHEUMATOID; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; GENETIC MARKERS; GENOMICS; HUMANS; INFANT; INFANT, NEWBORN; QUANTITATIVE TRAIT, HERITABLE; RISK FACTORS;

EID: 33746894198     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000240359.30303.e4     Document Type: Review

References (87)

1. Brewer EJ Jr, Bass J, Baum J, et al. Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. Arthritis Rheum 1977; 20:195-199.
2. Ramanan AV, Grom AA. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis? Rheumatology (Oxford) 2005; 44:1350-1353.
3. Pascual V, Allantaz F, Arce E, et al. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005; 201:1479-1486.
4. Duffy CM, Colbert RA, Laxer RM, et al. Nomenclature and classification in chronic childhood arthritis: time for a change? Arthritis Rheum 2005; 52:382-385.
5. Fink CW. Proposal for the development of classification criteria for idiopathic arthritides of childhood. J Rheumatol 1995; 22:1566-1569.
6. Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25:1991-1994.
7. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31:390-392.
8. Glass DN, Giannini EH. Juvenile rheumatoid arthritis as a complex genetic trait. Arthritis Rheum 1999; 42:2261-2268.
9. Moroldo MB, Chaudhari M, Shear E, et al. Juvenile rheumatoid arthritis affected sibpairs: extent of clinical phenotype concordance. Arthritis Rheum 2000; 50:1928-1934.
10. Prahalad S, Ryan MH, Shear ES, et al. Juvenile rheumatoid arthritis: linkage to HLA demonstrated by allele sharing in affected sibpairs. Arthritis Rheum 2000; 43:2335-2338.
11. Prahalad S, Shear ES, Thompson SD, et al. Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis. Arthritis Rheum 2002; 46:1851-1856.
12. Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes Immun 2002; 3:235-249.
13. Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005; 52:1138-1147.
14. Zeggini E, Packham J, Donn R, et al. Association of HLA-DRB1*13 with susceptibility to uveitis in juvenile idiopathic arthritis in two independent data sets. Rheumatology (Oxford) 2006; Feb 22 [Epub ahead of print] An association between HLA-DRB1'13 and uveitis was reported in a cohort of British oligoarticular JIA patients. These findings were replicated in an independent cohort highlighting the potential for future genetic screening for disease characteristics.
15. Melin-Aldana H, Giannini EH, Taylor J, et al. Human leukocyte antigen-DRB1'1104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis. J Pediatr 1992; 121:56-60.
16. Bukulmez H, Fife M, Tsoras M, et al. Tapasin gene polymorphism in systemic onset juvenile rheumatoid arthritis: a family-based case-control study. Arthritis Res Ther 2005; 7:R285-R290.
17. Phelan JD, Thompson SD, Glass DN. Susceptibility to JRA/JIA: complementing general autoimmune and arthritis traits. Genes Immun 2006; 7:1-10. This detailed review includes a comprehensive listing of candidate gene studies in juvenile arthritis with replicated findings.
18. Oen K, Malleson PN, Cabral DA, et al. Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis. Rheumatology (Oxford) 2005; 44:1115-1121.
19. Schmeling H, Biber D, Heins S, et al. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis. J Rheumatol 2005; 32:1832-1836.
20. Spector TD, Ahmadi KR, Valdes AM. When is a replication not a replication? Or how to spot a good genetic association study. Arthritis Rheum 2006; 54:1051-1054.
21. Agarwal K, Jones DE, Daly AK, et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 2000; 32:538-541.
22. Barreto M, Santos E, Ferreira R, et al. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet 2004; 12:620-626.
23. Braun J, Donner H, Siegmund T, et al. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 1998; 51:563-566.
24. Lei C, Dongqing Z, Yeqing S, et al. Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population. Eur J Hum Genet 2005; 13:823-828.
25. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423:506-511.
26. Suppiah V, O'Doherty C, Heggarty S, et al. The CTLA4+49A/G and CT60 polymorphisms and chronic inflammatory arthropathies in Northern Ireland. Exp Mol Pathol 2006; 80:141-146.
27. Miterski B, Drynda S, Boschow G, et al. Complex genetic predisposition in adult and juvenile rheumatoid arthritis. BMC Genet 2004; 5:2.
28. Prahalad S, Honeggar M, Thompson S, et al. Lack of association of CTLA4 polymorphisms with juvenile rheumatoid arthritis. Arthritis Rheum 2005; 52:S302.
29. Criswell LA, Pfeiffer KA, Lum RF, et al. Analysis of families in the Multiple Autoimmune Disease Genetics Consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005; 76:561-571. The recently discovered functional SNP (R620W) in PTPN22 was found to be associated with multiple autoimmune diseases including T1D, rheumatoid arthritis, SLE, and Hashimoto thyroiditis, but not in multiple sclerosis. This study suggests that functional SNPs may confer susceptibility to some, but not all, autoimmune disorders possibly reflecting different pathways to disease.
30. Viken MK, Amundsen SS, Kvien TK, et al. Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun 2005; 6:271-273. This study presented the first reported association of PTPN22 to JIA. PTPN22 is the leading example of a genetic variant that confers risk of developing diverse human autoimmune disease, including JIA.
31. Hinks A, Barton A, John S, et al. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: Further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 2005; 52:1694-1699. This case-control study replicated the previously reported associations to rheumatoid arthritis and JIA. This larger study in a unique replication cohort of JIA patients confirmed the role of PTPN22 in disease susceptibility.
32. Seldin MF, Shigeta R, Laiho K, et al. Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes Immun 2005; 6:720-722. The results of this study may not support the earlier findings of the PTPN22 SNP association with JIA; the sample size was small, however, and trends were reported.
33. Carlton VE, Hu X, Chokkalingam AP, et al. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 2005; 77:567-581.
34. Epplen C, Rumpf H, Albert E, et al. Immunoprinting excludes many potential susceptibility genes as predisposing to early onset pauciarticular juvenile chronic arthritis except HLA class II and TNF. Eur J Immunogenet 1995; 22:311-322.
35. Rooney M, David J, Symons J, et al. Inflammatory cytokine responses in juvenile chronic arthritis. Br J Rheumatol 1995; 34:454-460.
36. Mangge H, Kenzian H, Gallistl S, et al. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum 1995; 38:211-220.
37. Ozen S, Alikasifoglu M, Bakkaloglu A, et al. Tumour necrosis factor alpha G->A -238 and G->A -308 polymorphisms in juvenile idiopathic arthritis. Rheumatology (Oxford) 2002; 41:223-227.
38. Zeggini E, Thomson W, Kwiatkowski D, et al. Linkage and association studies of single-nucleotide polymorphism-tagged tumor necrosis factor haplotypes in juvenile oligoarthritis. Arthritis Rheum 2002; 46:3304-3311.
39. Nikitina Zake L, Cimdina I, Rumba I, et al. Major histocompatibility complex class I chain related (MIC) A gene, TNFa microsatellite alleles and TNFB alleles in juvenile idiopathic arthritis patients from Latvia. Hum Immunol 2002; 63:418-423.
40. Date Y, Seki N, Kamizono S, et al. Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5′-flanking region of the TNFalpha gene and HLA genes. Arthritis Rheum 1999; 42:2577-2582.
41. Modesto C, Patino-Garcia A, Sotillo-Pineiro E, et al. TNF-alpha promoter gene polymorphisms in Spanish children with persistent oligoarticular and systemic-onset juvenile idiopathic arthritis. Scand J Rheumatol 2005; 34:451-454.
42. Schmeling H, Wagner U, Peterson A, et al. Tumor necrosis factor alpha promoter polymorphisms in patients with juvenile idiopathic arthritis. Clin Exp Rheumatol 2006; 24:103-108.
43. Leech M, Metz C, Hall P, et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999; 42:1601-1608.
44. Donn RP, Shelley E, Ollier WE, et al. A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001; 44:1782-1785.
45. Donn R, Alourfi Z, De Benedetti F, et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46:2402-2409.
46. Baugh JA, Chitnis S, Donnelly SC, et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002; 3:170-176.
47. Radstake TR, Sweep FC, Welsing P, et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 2005; 52:3020-3029.
48. Plenge RM, Padyukov L, Remmers EF, et al. Replication of Putative Candidate-Gene Associations with Rheumatoid Arthritis in >4000 Samples from North America and Sweden: Association of Susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005; 77:1044-1060. This study focusing on adult rheumatoid arthritis, represents one of the first of its kind in the field of autoimmune genetic research. Ideal sample sizes and replication cohorts are reported for multiple candidate genes.
49. Donn R, Alourfi Z, Zeggini E, et al. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum 2004; 50:1604-1610.
50. Hurvitz JR, Suwairi WM, Van Hul W, et al. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet 1999; 23:94-98.
51. Lamb R, Thomson W, Ogilvie E, et al. Wnt-1-inducible signaling pathway protein 3 and susceptibility to juvenile idiopathic arthritis. Arthritis Rheum 2005; 52:3548-3553. This was a novel candidate gene study in JIA that was able to screen for functional variations in the gene, clearly stratify the disease population, and perform a replication study.
52. Giacopelli F, Marciano R, Pistorio A, et al. Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiol Genomics 2004; 20:87-96.
53. Marciano R, Giacopelli F, Divizia MT, et al. A polymorphic variant inside the osteopontin gene shows association with disease course in oligoarticular juvenile idiopathic arthritis. Ann Rheum Dis 2006; 65:662-665.
54. Ogilvie EM, Fife MS, Thompson SD, et al. The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families. Arthritis Rheum 2003; 48:3202-3206.
55. Fife MS, Ogilvie EM, Kelberman D, et al. Novel IL-6 haplotypes and disease association. Genes Immun 2005; 6:367-370.
56. Gibbons L J, Thomson W, Zeggini E, et al. The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis. Rheumatology (Oxford) 2005; 44:1390-1393.
57. Lamb R, Zeggini E, Thomson W, et al. Toll-like receptor 4 gene polymorphisms and susceptibility to juvenile idiopathic arthritis. Ann Rheum Dis 2005; 64:767-769.
58. Plenge R, Rioux JD. Identifying susceptibility genes for immunological disorders: patterns, power, and proof. Immunol Rev 2006; 210:40-51.
59. Zeggini E, Thomson W, Alansari A, et al. Tumour necrosis factor receptor II polymorphism and juvenile idiopathic arthritis. Rheumatology (Oxford) 2002; 41:462-465.
60. Zeggini E, Donn RP, Ollier WE, et al. Evidence for linkage of HLA loci in juvenile idiopathic oligoarthritis: independent effects of HLA-A and HLA-DRB1. Arthritis Rheum 2002; 46:2716-2720.
61. Oen K, El-Gabalawy HS, Canvin JM, et al. HLA associations of seropositive rheumatoid arthritis in a Cree and Ojibway population. J Rheumatol 1998; 25:2319-2323.
62. Oen K, Schroeder M, Jacobson K, et al. Juvenile rheumatoid arthritis in a Canadian First Nations (aboriginal) population: onset subtypes and HLA associations. J Rheumatol 1998; 25:783-790.
63. Garavito G, Yunis EJ, Egea E, et al. HLA-DRB1 alleles and HLA-DRB1 shared epitopes are markers for juvenile rheumatoid arthritis subgroups in Colombian mestizos. Hum Immunol 2004; 65:359-365.
64. Vencovsky J, Jarosova K, Ruzickova S, et al. Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile idiopathic arthritis. Arthritis Rheum 2001; 44:2387-2391.
65. Cinek O, Vavrincova P, Striz I, et al. Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. J Rheumatol 2004; 31:1206-1210.
66. Runstadler JA, Saila H, Savolainen A, et al. Association of SLC11A1 (NRAMP1) with persistent oligoarticular and polyarticular rheumatoid factor-negative juvenile idiopathic arthritis in Finnish patients: haplotype analysis in Finnish families. Arthritis Rheum 2005; 52:247-256.
67. Saila H, Pitkaniemi J, Tuomilehto J, et al. HLA and susceptibility to juvenile idiopathic arthritis: a study of affected sibpairs in an isolated Finnish population. J Rheumatol 2004; 31:2281-2285.
68. Pratsidou-Gertsi P, Kanakoudi-Tsakalidou F, Spyropoulou M, et al. Nationwide collaborative study of HLA class II associations with distinct types of juvenile chronic arthritis (JCA) in Greece. Eur J Immunogenet 1999; 26:299-310.
69. De Benedetti F, Meazza C, Vivarelli M, et al. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2003; 48:1398-1407.
70. Sanjeevi CB, Miller EN, Dabadghao P, et al. Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis. Arthritis Rheum 2000; 43:1397-1404.
71. Smerdel A, Dai KZ, Lorentzen AR, et al. Genetic association between juvenile rheumatoid arthritis and polymorphism in the SH2D2A gene. Genes Immun 2004; 5:310-312.
72. Smerdel A, Lie BA, Ploski R, et al. A gene in the telomeric HLA complex distinct from HLA-A is involved in predisposition to juvenile idiopathic arthritis. Arthritis Rheum 2002; 46:1614-1619.
73. Smerdel A, Ploski R, Flato B, et al. Juvenile idiopathic arthritis (JIA) is primarily associated with HLA-DR8 but not DQ4 on the DR8-DQ4 haplotype. Ann Rheum Dis 2002; 61:354-357.
74. Berdeli A, Ozyurek AR, Ulger Z, et al. Association of macrophage migration inhibitory factor gene -173 G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis. Rheumatol Int 2005; 26:1-6.
75. Prahalad S, Kingsbury DJ, Griffin TA, et al. Polymorphism in the MHC-encoded LMP7 gene: association with JRA without functional significance for immunoproteasome assembly. J Rheumatol 2001; 28:2320-2325.
76. Moroldo MB, Donnelly P, Saunders J, et al. Transmission disequilibrium as a test of linkage and association between HLA alleles and pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 1998; 41:1620-1624.
77. Murray KJ, Moroldo MB, Donnelly P, et al. Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles. Arthritis Rheum 1999; 42:1843-1853.
78. Thompson SD, Moroldo MB, Guyer L, et al. A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage. Arthritis Rheum 2004; 50:2920-2930.
79. Prahalad S, Bohnsack JF, Jorde LB, et al. Association of two functional polymorphisms in the CCR5 gene with juvenile rheumatoid arthritis. Genes Immun (in press).
80. Graham TB, Glass DN. Juvenile rheumatoid arthritis: ethnic differences in diagnostic types. J Rheumatol 1997; 24:1677-1679.
81. Baechler EC, Batliwalla FM, Reed AM, et al. Gene expression profiling in human autoimmunity. Immunol Rev 2006; 210:120-137. Gene expression profiling has revealed some common themes for autoimmunity, including IFNγ signatures, dysregulated cytokine and chemokines genes and overlapping transcriptional signatures.
82. Bennett L, Palucka AK, Arce E, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197:711-723.
83. Palucka AK, Blanck JP, Bennett L, et al. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci USA 2005; 102:3372-3377.
84. Barnes MG, Aronow BJ, Luyrink LK, et al. Gene expression in juvenile arthritis and spondyloarthropathy: pro-angiogenic ELR+ chemokine genes relate to course of arthritis. Rheumatology (Oxford) 2004; 43:973-979.
85. Jarvis JN, Dozmorov I, Jiang K, et al. Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis. Arthritis Res Ther 2004; 6:R15-R32.
86. Jarvis JN. Gene expression profiling in pediatric rheumatic disease: what have we learned? What can we learn? Curr Opin Rheumatol 2005; 17:606-611.
87. Fernald GH, Yeh RF, Hauser SL, et al. Mapping gene activity in complex disorders: Integration of expression and genomic scans for multiple sclerosis. J Neuroimmunol 2005; 167:157-169. This study demonstrated a powerful approach to integrative analysis of linkage and association studies with large scale expression studies to dissect complex genetic traits.